Fleury Group Bringing Ariosa's Harmony NIPD to Brazil | GenomeWeb

NEW YORK (GenomeWeb News) – Ariosa Diagnostics today said it has reached a deal with Fleury Medicina e Saude (Fleury Group) to provide Ariosa's non-invasive prenatal diagnostic test in Brazil.

The Fleury Group will distribute the Harmony Prenatal Test within its network of more than 3,000 clinical laboratories and hospitals throughout the country, which Ariosa said has an annual birth rate of almost 3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.